Oxbridge Re reports successful returns on tokenized reinsurance securities

Oxbridge Re reports successful returns on tokenized reinsurance securities | Insurance Business Australia

Reinsurance

Oxbridge Re reports successful returns on tokenized reinsurance securities

RWAs’ performance exceeded projections

Reinsurance

By
Kenneth Araullo

Oxbridge Re Holdings and its subsidiaries, which focus on tokenized Real-World Assets (RWAs) and reinsurance solutions for property and casualty insurers, announced that its Web3 subsidiary, SurancePlus Inc, achieved a 49.11% return on its tokenized reinsurance security, DeltaCat Re.

The reinsurance group noted that this performance exceeded the initial return on investment (ROI) projection of 42%.

DeltaCat Re digital security was made available to US accredited investors under Rule 506(c) of the US Securities and Exchange Commission (SEC) Regulation D and to non-U.S. investors under Regulation S of the U.S. Securities Act of 1933, as amended.

Jay Madhu (pictured above), president and CEO of Oxbridge Re, stated that last year, SurancePlus enhanced Oxbridge Re’s special purpose vehicle, Oxbridge Re NS, by integrating digital innovations and offering an RWA tokenized security.

“Last year, SurancePlus enhanced Oxbridge Re’s special purpose vehicle, Oxbridge Re NS, by integrating digital innovations and insights by offering an RWA tokenized security, thus making reinsurance more accessible as an alternative investment through the Avalanche blockchain. We are pleased with the impressive returns for DeltaCat Re token investors. Looking ahead, we are excited about the long-term prospects of our business as we approach the close of our capital raise for the 2024/25 EpsilonCat Re Token,” Madhu said.

In other developments, however, the company’s board of directors announced that it is evaluating a range of strategic options, including a potential sale, spinoff, merger, divestiture, or recapitalization.

It explained that it is reviewing alternatives to maximize shareholder value and will consider options for both the company and its subsidiary, SurancePlus.

“The company cannot assure that its evaluation will result in the company and/or its subsidiaries pursuing a transaction or that any transaction, if pursued, will be completed on attractive terms,” Oxbridge Re said in its statement.

What are your thoughts on this story? Please feel free to share your comments below.